Press release
Gout Therapeutics Market Size, Share, Trends, Growth, Regional Outlook and Forecast 2017 - Credence Research
Browse the full report Gout Therapeutics Market - Growth, Future Prospects and Competitive Analysis, 2017 – 2025 report at http://www.credenceresearch.com/report/gout-therapeutics-market
Market Insights
Gout is a complex form of inflammatory arthritis characterized by acute intermittent episodes of inflammation and pain. Gout therapeutics market is rapidly growing due to factors such as increasing incidence of gout, significant unmet needs and rising number of obese and geriatric population. Strategic partnership of key players with small manufacturers in the market is expected to drive market growth during forecast period. In April 2016, AstraZeneca entered into licensing agreement with Ironwood Pharmaceuticals, which granted the United States exclusive rights to AstraZeneca for Zurampic (lesinurad) and it is expected that AstraZeneca will successfully promote Zurampic in the United States which would further drive the gout therapeutics market growth.
For the purpose of study, global gout therapeutics market is segmented on the basis of drug classes such as non-steroidal anti-inflammatory drugs (NSAIDs), colchicine, corticosteroids and uric acid lowering agents. Currently, the trend of administering combination of uric acid lowering agents is observed in the market and it is estimated that it will show significant market growth during forecast period due to its effectiveness and lower adverse effects. The newly approved drug, Duzallo (lesinurad and allopurinol), approved in 2017 is expected to exceed total annual U.S. peak sales of $300 million. Strong presence of pipeline molecules such as arhalofenate, bucillamine, levotofisopam, ulodesine, verinurad etc. is expected to assist in achieving significant market growth over the forecast period 2017-2025. In the recent years, demand for biologics has increased in market due to its target specificity. Approved biologics such as Canakinumab and Krystexxa are driving the growth of gout therapeutics market globally.
Geographically, the global gout therapeutics market is currently dominated by North America, factors such as higher cost of therapeutics, increase in number of gout patients, favorable government reimbursement policies in healthcare systems and high healthcare awareness are fueling the growth of gout therapeutics market in North America. Expected launch of novel therapeutics such as halofenate, bucillamine, levotofisopam, ulodesine, verinurad would further assist market growth during the forecast period. However, Asia Pacific is expected to show fastest market growth during forecast period due to developing economic conditions, rising healthcare awareness and rapid evolution of healthcare infrastructure would drive the market growth during forecast period.
Market Competition Assessment:
The gout therapeutics market is observed to be highly competitive and comprises large number of players. The market is currently dominated by few players such as Ardea Biosciences Inc., AstraZeneca plc., BioCryst Pharmaceuticals Inc., Cymabay Therapeutics, Inc., GlaxoSmithKline plc., Horizon Pharma Plc., Novartis AG, Regeneron Pharmaceuticals Inc., Sanofi Aventis, Savient Pharmaceuticals, Inc., Selecta Biosciences, Inc., Takeda Pharmaceutical Company Ltd., Teijin Pharma Ltd., and other.
Key Market Movements:
Factors such as rising prevalence of gout, strong presence of pipeline molecules, increasing treatment awareness, and favorable reimbursement policies in developed countries are driving the market growth of gout therapeutics
Due to the higher unmet needs, vendors in the market are focusing in development of ideal treatment, promising pipeline molecule, rising access for the treatment medication in some developing countries the growth of gout therapeutics market during forecast period is ensured
However, popularity of lower cost OTC drugs and patient preference for home remedies are negatively impacting the growth of gout therapeutics market globally
To Get Complete Report @ http://www.credenceresearch.com/report/gout-therapeutics-market
Browse All Reports of This Category :- http://www.credenceresearch.com/industry/pharmaceuticals-market
Blog : http://www.mobilecomputingtoday.co.uk/6985/gout-therapeutics-market-expanding-cagr-15-6-2017-2025-credence-research/
Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non-legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we’ve manufactured a firm extraordinarily prepared to this task.
Name: Chris Smith
Designation: Global Sales Manager
E-mail: sales@credenceresearch.com
Ph: 1-800-361-8290
Web: http://www.credenceresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Gout Therapeutics Market Size, Share, Trends, Growth, Regional Outlook and Forecast 2017 - Credence Research here
News-ID: 934568 • Views: …
More Releases from Credence Research Inc
Trauma Products Market Projected to Hit USD 14806.4 Million by 2032, Expanding a …
Market Overview
The Trauma Products Market size was valued at USD 9575 million in 2024 and is anticipated to reach USD 14806.4 million by 2032, at a CAGR of 5.6% during the forecast period.
Strong demand for trauma products stems from rising accident rates and increased surgical procedures across hospitals worldwide. Growing elderly populations prone to fractures boost need for fixation devices and implants. Healthcare providers upgrade trauma care infrastructure to handle…
Laminated Can Packaging Market Projected to Hit USD 15463 Million by 2032, Expan …
Market Outlook
The Laminated Can Packaging market reached USD 10,230 million in 2024 and is expected to grow to USD 15,463 million by 2032, posting a CAGR of 5.3% during the forecast period. Demand rises due to strong use in food, beverage, and personal care products. Brands adopt laminated cans to gain better shelf appeal and longer product safety. Growth also comes from rising interest in lightweight and corrosion-resistant formats. Manufacturers…
Americas-blood-glucose-test-strip-packaging-market to Reach USD 341.2 million by …
Market Overview:
The Americas-blood-glucose-test-strip-packaging-market continues to expand due to rising diabetes screening and stronger adoption of home-based testing solutions. The Americas-blood-glucose-test-strip-packaging-market size was valued at USD 231 million in 2024 and is anticipated to reach USD 341.2 million by 2032, at a CAGR of 5% during the forecast period.
The Americas-blood-glucose-test-strip-packaging-market grows due to stronger use of self-monitoring tools among diabetic patients and wider access to fast diagnostic kits. Producers develop…
Global Coated Recycled Paperboard Market Projected to Hit USD 14,458.7 Million b …
Market Overview
The Global Coated Recycled Paperboard Market size was valued at USD 10,001.4 million in 2024 and is anticipated to reach USD 14,458.7 million by 2032, at a CAGR of 4.70% during the forecast period.
Growing adoption across FMCG, food and beverage, household goods, and personal care drives higher market engagement. Companies select coated recycled paperboard to balance cost efficiency with stronger sustainability commitments. It supports better packaging visibility…
More Releases for Gout
Chronic Gout Market Trends, Therapeutics, and Growth Opportunities
Chronic gout is a progressive form of arthritis characterized by elevated uric acid levels, leading to severe joint pain, inflammation, and long-term joint damage. This condition affects millions worldwide, often resulting in impaired mobility and reduced quality of life. With rising prevalence due to lifestyle changes, aging populations, and dietary habits, the Chronic Gout market is witnessing a surge in demand for advanced therapeutics, early diagnostics, and patient management solutions.
Download…
Chronic Gout Market Massive Growth opportunity Ahead
Introduction
Chronic gout is a form of arthritis characterized by recurrent attacks of severe pain, swelling, and inflammation in the joints, often due to the accumulation of uric acid crystals. This condition typically affects the big toe but can also impact other joints, including the knees, elbows, and wrists. Uric acid, a by-product of purine metabolism, accumulates in the body due to overproduction or underexcretion by the kidneys, leading to hyperuricemia…
Gout Market Innovations in Pain Management and Treatment
On April 08, 2025, Exactitude Consultancy., Ltd. announces the release of the report "Global Gout Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2034". The report is a detailed and comprehensive analysis presented by region and country, type and application. As the market is constantly changing, the report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many…
Gout Therapeutics Market Analysis By Drug Class (Nonsteroidal Anti-inflammatory …
Report Summary
The global gout therapeutics market was valued at USD 2.78 Billion in 2021 and is expected to grow at a CAGR of 13.7% during the forecast period 2023-2032.
Gout Therapeutics Market Introduction
The deposition of monosodium crystals (MSU) into the distal joints and peripheral tissues results in gout, an inflammatory arthritic disease. Gout is a typical type of painful inflammatory arthritis. One joint is typically affected at a time (often…
Global Gout Drugs Market Analysis (2020-2025)
Global Info Research offers a latest published report on Gout Drugs Analysis and Forecast 2020-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key global Gout Drugs Concentrate players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
Click to view the full report TOC, figure and tables:
https://www.globalinforesearch.com/reports/371311/gout-drugs
Market…
Gout Therapeutics Market Emerging Trends And Forecast By 2025
Global Gout Therapeutics Market: Snapshot
The objective of treatment during a severe gout attack involves suppressing inflammation and controlling pain. The treatment of inflammation and pain can be attained with non-steroidal anti-inflammatory drugs, colchicine, or corticosteroids. The line of treatment chosen that would be suitable depends on the co-morbid medical conditions of the patient, side effect profile, and other medications.
Patients with multiple episodes of severe gout attacks every year or with…
